« back to directory
About Nucleus Network
Nucleus Network is a leading early phase clinical research organisation in Australia, providing an expedited regulatory pathway, the CTN scheme, for the initiation of first-in-human clinical trials without the need for filing an IND.
Nucleus Network is located at the AMREP Centre for Clinical Studies (a 50-bed early phase clinical trial unit co-located with the Alfred Medical Research Education Precinct at the Alfred Hospital), and are a not-for-profit organisation, wholly owned by the Baker IDI Heart and Diabetes Institute, allowing reinvestment into the business to support quality clinical outcomes.